Particularly, the observed Cyr61 mRNA level was previously reported to be a pro-angiogenic and tumor-promoting factor in renal, breast, pancreas and lung cancer cell lines [48], [49], [50]. This evidence concerns the gene CCN1 and lung carcinoma.